VANCOUVER, British Columbia, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Kaneh Bosm BioTechnolgy Inc. (CSE: KBB)(FWB: 8K51)(OTC: KNHBF)(“Kaneh Bosm” or the “Company”) is pleased to announce that it has secured eligibility by The Depository Trust Company (DTC) for its shares on the OTC Markets. DTC is a subsidiary of the Depository Trust & Clearing Corp (DTCC) that manages the electronic clearing and settlement of publicly traded companies in the United States.

Further to the company's news release dated August 14, 2018, Kaneh Bosm’s common shares are now fully DTC eligible and trade under the symbol KNHBF on the OTC Markets. Securities that are eligible to be electronically cleared and settled through the DTC are considered DTC eligible. This electronic method of clearing securities speeds up the receipt of stock and cash, and thus accelerates the settlement process for investors.

Kaneh Bosm’s Chief Executive Officer, Eugene Beukman, states, "We are very pleased to have obtained DTC eligibility. This status will make the process of trading our stock in the United States much easier. We expect that this will make our shares available to a larger percentage of the investment market, which should improve the liquidity of our shares and therefore benefit Kaneh Bosm and our shareholders."

On behalf of the Board of Directors of Kaneh Bosm Biotechnology Inc.

“Michael Martinz”

Michael Martinz
President, Director
mmartinz@kanehbosmbiotech.com

THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

© 2024 Canjex Publishing Ltd. All rights reserved.